Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 49, 2019 - Issue 9
296
Views
3
CrossRef citations to date
0
Altmetric
Articles

Synthesis and characterization of novel chiral imidazolium and pyridinium ionic liquids derived from tartaric acid and 2-oxazolidinone

, , , &
Pages 1173-1180 | Received 20 Dec 2018, Published online: 02 Apr 2019
 

Abstract

Novel chiral imidazolium and pyridinium ionic liquids based on tartaric acid and 2-oxazolidinone were designed. Symmetrical dicationic ionic liquids based on tartaric acid have been synthesized and characterized. These chiral ionic liquids were designed by employing very short and simple methods. Incorporation of alkyl halide over tartaric acid and 2-oxazolidinone is an important step. N-methyl imidazole and pyridine were used for preparation of quaternary salts. These ionic liquids have been evaluated for the asymmetric sulfide oxidation. Chiral ionic liquids based on tartaric acid showed superior chiral inducing property as compare to 2-oxazolidinone based chiral ionic liquids.

GRAPHICAL ABSTRACT

Acknowledgments

The authors are thankful to the M/S Lupin Limited and the authorities of Manipal Academy of Higher Education for the research program. We also acknowledge the valuable guidance, support, and suggestions from Dr. P. R. Upadhaya, and Dr. Vijaya Desai.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.